APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 42 filers reported holding APPLIED DNA SCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $16,000 | -11.1% | 12,577 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $18,000 | -30.8% | 12,577 | -24.1% | 0.01% | -27.3% |
| Q4 2017 | $26,000 | -50.9% | 16,580 | -10.0% | 0.01% | -52.2% |
| Q3 2017 | $53,000 | +65.6% | 18,412 | 0.0% | 0.02% | +64.3% |
| Q2 2017 | $32,000 | +45.5% | 18,412 | +37.3% | 0.01% | +40.0% |
| Q1 2017 | $22,000 | -43.6% | 13,412 | -35.9% | 0.01% | -44.4% |
| Q4 2016 | $39,000 | -39.1% | 20,921 | 0.0% | 0.02% | -41.9% |
| Q3 2016 | $64,000 | -5.9% | 20,921 | 0.0% | 0.03% | -8.8% |
| Q2 2016 | $68,000 | -5.6% | 20,921 | 0.0% | 0.03% | -8.1% |
| Q1 2016 | $72,000 | +5.9% | 20,921 | 0.0% | 0.04% | +5.7% |
| Q4 2015 | $68,000 | -36.4% | 20,921 | 0.0% | 0.04% | -39.7% |
| Q3 2015 | $107,000 | +224.2% | 20,921 | +95.1% | 0.06% | +262.5% |
| Q2 2015 | $33,000 | +17.9% | 10,721 | 0.0% | 0.02% | +14.3% |
| Q1 2015 | $28,000 | -9.7% | 10,721 | 0.0% | 0.01% | -6.7% |
| Q4 2014 | $31,000 | – | 10,721 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHASE INVESTMENT COUNSEL CORP | 261,163 | $104,000 | 0.06% |
| Benchmark Capital Advisors | 50,000 | $20,000 | 0.02% |
| Quadrant Private Wealth Management, LLC | 20,000 | $8,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 60,835 | $24,000 | 0.01% |
| BREWIN DOLPHIN LTD | 82,969 | $33,188 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $20,000 | 0.00% |
| TAURUS ASSET MANAGEMENT, LLC | 10,000 | $4,000 | 0.00% |
| MYCIO WEALTH PARTNERS, LLC | 25,000 | $10,000 | 0.00% |
| Onex Canada Asset Management Inc. | 20,000 | $8,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,200 | $14,000 | 0.00% |